Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Biogen Inc. (BIIB)

« Back to company index

BIIB Chatter Timeline

Stock Ticker for BIIB

Most Active Tweeters for BIIB

UserTweets
@Gambiste1 17
@StckPro 13
@EnixBlockchain 10
@Tickeron 9
@1MinuteStock 9

Recent Tweets for BIIB

TheBiotechBeat @TheBiotechBeat
RT @AndyBiotech: My proposal for $BIIB aducanumab situation Require another trial before approval but allow "Expanded Access" with cost re…
December 6th 2019, 11:12pm
Varro_Analytics @Varro_Analytics
RT @zbiotech: LR $BIIB KOL event: 'At our dinner the specialists suggested that they thought the probability of approval was much higher,…
December 6th 2019, 11:12pm
MC_OptionTrades @MC_OptionTrades
$BIIB Option Order Flow Sentiment is 56.9% Bullish. https://t.co/4wORyOdMjk
December 6th 2019, 9:12pm
AdamJButler @AdamJButler
Something I can’t figure out from the aducanumab results; $biib dropped more than 100 patients from the studies bec… https://t.co/HM10g4O9qj
December 6th 2019, 9:12pm
Gambiste1 @Gambiste1
RT @RichardRoma6000: When effort and drama are gold standard for drug approval $BIIB #cringe According to two doctors, it's now "virtua…
December 6th 2019, 8:12pm
Gambiste1 @Gambiste1
RT @boneapalooza: Waiting for somebody to figure out what this $BIIB data means... https://t.co/YzOOKMEkWX
December 6th 2019, 8:12pm
RichardRoma6000 @RichardRoma6000
When effort and drama are gold standard for drug approval $BIIB #cringe According to two doctors, it's now "vir… https://t.co/ifYTuT6Ltb
December 6th 2019, 8:12pm
alim1 @alim1
@sciencescanner I think $BIIB are doing a huge disservice to patients, their families, doctors and biotech in even… https://t.co/C0Fzx8SQMQ
December 6th 2019, 6:12pm
HubBucket @HubBucket
RT @RebeccaDRobbins: I wrote about the stagecraft of the closely watched $BIIB data reveal at #ctad19 https://t.co/t7xb8X4k03
December 6th 2019, 6:12pm
IncredibleTrade @IncredibleTrade
Provided $BIIB range when it was halted yesterday .. (276-307) ! https://t.co/uKqHk2TGwh
December 6th 2019, 5:12pm
alleolabs @alleolabs
Brilliant article on $BIIB ‘s “David Copperfield” level of illusions (The Statue of Liberty was there the whole tim… https://t.co/1Tj9Mnei0d
December 6th 2019, 5:12pm
AmericanBanking @AmericanBanking
Biogen $BIIB Receives Hold Rating from Raymond James https://t.co/L9tfqceHcl #stocks
December 6th 2019, 5:12pm
dispatchtribune @dispatchtribune
Raymond James Reiterates “Hold” Rating for Biogen $BIIB https://t.co/6h5k8OQ9BK
December 6th 2019, 5:12pm
EnterpriseLeade @EnterpriseLeade
Biogen $BIIB Receives “Hold” Rating from Raymond James https://t.co/disy0pw70j
December 6th 2019, 5:12pm
long_biotech @long_biotech
RT @matthewherper: Here is what I don't understand, $BIIB. If higher doses are what are causing the post-protocol analysis results to look…
December 6th 2019, 4:12pm
TopStockAlerts1 @TopStockAlerts1
$BIIB Alzheimer’s expert says more clinical trials are needed for controversial Biogen drug https://t.co/6JjwFNIkty
December 6th 2019, 4:12pm
GermanBiotech @GermanBiotech
An approval of #aducanumab $BIIB would be irresponsible! So far there is no serious proof of efficacy for aducanuma… https://t.co/A7oYZHeknI
December 6th 2019, 3:12pm
long_biotech @long_biotech
RT @TheIpHawk: @AndyBiotech They should open $BIIB at $220 where they pumped this data. Aduc has little chance and would be wasting the FDA…
December 6th 2019, 3:12pm
Hall8Jack @Hall8Jack
RT @jeff_cranmer: Apple Tree launches Limelight w/$75M, $BIIB vet Ehlers as CEO to use multi-platform approach to gene therapy to overcome…
December 6th 2019, 3:12pm
StckPro @StckPro
$BIIB NEW ARTICLE : Biogen (BIIB) Presents Aducanumab Phase 3 Topline Results - Slideshow https://t.co/Vu58IJdJhP G… https://t.co/sZnK1Qxmo0
December 6th 2019, 3:12pm
IBD_AGatlin @IBD_AGatlin
Will the FDA approve $BIIB's controversial #Alzheimers drug? #stocks #biotech #investingnews https://t.co/RR6S4lVj71
December 6th 2019, 2:12pm
optioncharts @optioncharts
$BIIB open interest for maturity 12/06/2019. High put=280.00 High call=310.00 PutCallRatio=1.19 #maxpain #options… https://t.co/Ks9niYBeFh
December 6th 2019, 2:12pm
SeekingAlpha @SeekingAlpha
$BIIB - Biogen (BIIB) Presents Aducanumab Phase 3 Topline Results - Slideshow. Read more and get updates on any sto… https://t.co/FOEG9uCja1
December 6th 2019, 2:12pm
b_ownthenight @b_ownthenight
$BIIB A close back below $300 would be a win for the bears...
December 6th 2019, 2:12pm
Lazarus_Playz @Lazarus_Playz
$BIIB hit 304.60 area then shit the bed. See if it closes over 302 which is still ok. Anything below and likely see… https://t.co/crcDoCd7ya
December 6th 2019, 2:12pm
StckPro @StckPro
$BIIB NEW ARTICLE : Will The FDA Approve Biogen's Controversial Alzheimer's Drug? https://t.co/yucg1QNCQN Get all t… https://t.co/uYEie43hUU
December 6th 2019, 2:12pm
sssvenky @sssvenky
If it stays this way, a nice weekly close on decent volume this week for $BIIB in addition to an inside day. @AOTtrades
December 6th 2019, 1:12pm
StckPro @StckPro
$BIIB NEW ARTICLE : Questions Linger After CTAD For Biogen's Aducanumab, But Trading Opportunities Exist… https://t.co/4D6KO4QuVk
December 6th 2019, 1:12pm
Lazarus_Playz @Lazarus_Playz
$BIIB a close over $306 and this gets nutty imo..
December 6th 2019, 1:12pm
SeekingAlpha @SeekingAlpha
$BIIB - Questions Linger After CTAD For Biogen's Aducanumab, But Trading Opportunities Exist. Follow this and any o… https://t.co/gNTMKMWrzT
December 6th 2019, 1:12pm
Redrichmond2 @Redrichmond2
RT @TraderJill77: I am not a shorter by any stretch of the imagination, but I'm betting against $BIIB now. This Alzheimer's data is a weak…
December 6th 2019, 1:12pm
ZolmaxNews @ZolmaxNews
Biogen Inc $BIIB Given Consensus Recommendation of “Hold” by Brokerages https://t.co/bvbdBSoTMF
December 6th 2019, 1:12pm
AmericanBanking @AmericanBanking
Biogen Inc $BIIB Given Consensus Recommendation of “Hold” by Brokerages https://t.co/rph183wM1g #stocks
December 6th 2019, 1:12pm
BretRosenthal @BretRosenthal
#ARMRreport White Board $BIIB Biogen Stock Pops: Here's What Happened In Its Alzheimer's Update https://t.co/ECkgP0P1ey via @IBDinvestors
December 6th 2019, 12:12pm
MOOZ_KNUCKLE @MOOZ_KNUCKLE
RT @StckPro: $BIIB NEW ARTICLE : Analyst: It's unclear whether Biogen's new Alzheimer's drug will get approved https://t.co/K4Wog5ppW0 Get…
December 6th 2019, 12:12pm
kblodg_15 @kblodg_15
I gave the market too much credit. Reactions from panelists picked by $BIIB is what's driving the stock. The stud… https://t.co/5ohWa1fnXL
December 6th 2019, 12:12pm
Hall8Jack @Hall8Jack
RT @FayCortez: Biogen: "Tag, FDA, you're it!" $BIIB to file for FDA approval of aducanumab with data it has now. It won't be easy. http…
December 6th 2019, 12:12pm
TraderJill77 @TraderJill77
I am not a shorter by any stretch of the imagination, but I'm betting against $BIIB now. This Alzheimer's data is a… https://t.co/7QYGwgh6IS
December 6th 2019, 12:12pm
StckPro @StckPro
$BIIB NEW ARTICLE : Analyst: It's unclear whether Biogen's new Alzheimer's drug will get approved… https://t.co/jvnAHyHkhL
December 6th 2019, 12:12pm
path1finder @path1finder
@zbiotech seems these KOLs get good money from $BIIB haha
December 6th 2019, 12:12pm
EvenWangMD @EvenWangMD
@zbiotech The easy thing to do is just to stay away from $biib, it's too hard to predict what's going to happen. D… https://t.co/NeaeN9Js7F
December 6th 2019, 12:12pm
EnixBlockchain @EnixBlockchain
Agnes projected $BIIB would out-perform the NASDAQ, it outperformed the NASDAQ by 0.85%, Did you outperform the NAS… https://t.co/5Lx8BW79q6
December 6th 2019, 12:12pm
zbiotech @zbiotech
LR $BIIB KOL event: 'At our dinner the specialists suggested that they thought the probability of approval was muc… https://t.co/LQS3OlY31i
December 6th 2019, 11:12am
newswelldone @newswelldone
$BIIB: Risks of Biogen Alzheimer’s Drug Are Clear, but Its Benefits Are Still Unproven, Says Raymond James: https://t.co/S81XSJtnvM
December 6th 2019, 11:12am
ScripVibhaRavi @ScripVibhaRavi
RT @ScripMandy: Worth noting that $BIIB already has said it will seek FDA approval for aducanumab in early 2020. VP Samantha Budd Haeberlei…
December 5th 2019, 11:12pm
alleolabs @alleolabs
RT @MaxJacobsEdison: So let me get this straight, $BIIB wants to have society pay billions of dollars to them for a drug with minimal effic…
December 5th 2019, 11:12pm
JuliaJoung @JuliaJoung
RT @RebeccaDRobbins: Our dispatch on $BIIB's noisy aducanumab data. I reported from #ctad19 in San Diego, and @matthewherper made sense of…
December 5th 2019, 11:12pm
Gambiste1 @Gambiste1
RT @jonathanrockoff: $BIIB up 3.4% after presenting data for its experimental Alzheimer’s drug, but skeptics remain, [email protected]? report…
December 5th 2019, 11:12pm
Gambiste1 @Gambiste1
RT @RebeccaDRobbins: When I asked $BIIB for comment on this, a co spokesperson said that audience members submitted questions online and th…
December 5th 2019, 11:12pm
TradeTexasBig @TradeTexasBig
$biib will probably try to market its drug as a alzheimers prevention than cure eventually ? ? more $ in false negative than false positive
December 5th 2019, 11:12pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.